We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIFS icon
2876
Hingham Institution for Saving
HIFS
$657M
$60K ﹤0.01%
208
+108
+108% +$31.7K
MCBS icon
2877
MetroCity Bankshares
MCBS
$1.02B
$60K ﹤0.01%
3,415
+1,476
+76% +$24.5K
MMI icon
2878
Marcus & Millichap
MMI
$1.16B
$60K ﹤0.01%
1,527
-5,928
-80% -$223K
NMM icon
2879
Navios Maritime Partners
NMM
$2.24B
$60K ﹤0.01%
2,045
+1,745
+582% +$50.6K
NNI icon
2880
Nelnet
NNI
$4.53B
$60K ﹤0.01%
808
-2,891
-78% -$217K
VXRT
2881
DELISTED
Vaxart
VXRT
$60K ﹤0.01%
7,977
+1,462
+22% +$10.2K
WKHS icon
2882
Workhorse Group
WKHS
$34.5M
$60K ﹤0.01%
1
-2
-67% -$74.1K
ENLC
2883
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$60K ﹤0.01%
9,432
-34,391
-78% -$176K
KDNY
2884
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$60K ﹤0.01%
4,278
+2,714
+174% +$43.4K
CAHC
2885
DELISTED
CA Healthcare Acquisition Corp. Class A Common Stock
CAHC
$60K ﹤0.01%
6,082
+5,982
+5,982% +$59.1K
AVAV icon
2886
AeroVironment
AVAV
$9.57B
$59K ﹤0.01%
588
-907
-61% -$99.8K
FC icon
2887
Franklin Covey
FC
$242M
$59K ﹤0.01%
1,801
-9,132
-84% -$282K
IDYA icon
2888
IDEAYA Biosciences
IDYA
$3.54B
$59K ﹤0.01%
2,796
-628
-18% -$12.9K
KFRC icon
2889
Kforce
KFRC
$1.04B
$59K ﹤0.01%
942
-873
-48% -$51.7K
KIDS icon
2890
OrthoPediatrics
KIDS
$608M
$59K ﹤0.01%
931
+329
+55% +$18.9K
ORA icon
2891
Ormat Technologies
ORA
$6.87B
$59K ﹤0.01%
843
-9,223
-92% -$656K
PNQI icon
2892
Invesco NASDAQ Internet ETF
PNQI
$545M
$59K ﹤0.01%
1,155
-23,385
-95% -$1.13M
TDUP icon
2893
ThredUp
TDUP
$424M
$59K ﹤0.01%
2,035
+690
+51% +$14.9K
VXUS icon
2894
Vanguard Total International Stock ETF
VXUS
$162B
$59K ﹤0.01%
902
+177
+24% +$11.6K
NTCO
2895
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$59K ﹤0.01%
+2,622
New +$51.5K
FMTX
2896
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$59K ﹤0.01%
2,363
-1,876
-44% -$50.4K
HSKA
2897
DELISTED
Heska Corp
HSKA
$59K ﹤0.01%
257
-374
-59% -$73.4K
ANIP icon
2898
ANI Pharmaceuticals
ANIP
$1.72B
$58K ﹤0.01%
1,655
+1,134
+218% +$38.6K
AORT icon
2899
Artivion
AORT
$1.28B
$58K ﹤0.01%
2,027
-9,279
-82% -$253K
AVDL
2900
DELISTED
Avadel Pharmaceuticals
AVDL
$58K ﹤0.01%
8,497
+5,530
+186% +$43.9K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.